Expand AMRX Menu
AMRX MENU

AMRX Stock Summary and Trading Ideas (Amneal Pharmaceuticals - Class A | NASDAQ:AMRX)

Charts for Today's Stock Price and Implied Volatility in Amneal Pharmaceuticals - Class A

10-May-2024

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for AMRX by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Amneal Pharmaceuticals - Class A (AMRX) Frequently Asked Questions

What does Amneal Pharmaceuticals - Class A do?

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

What symbol and exchange does Amneal Pharmaceuticals - Class A stock trade?

Amneal Pharmaceuticals - Class A trades on the NASDAQ stock market under the symbol AMRX.

What is Amneal Pharmaceuticals - Class A stock price doing today?

As of May 10, 2024, AMRX stock price climbed to $6.66 with 1,091,065 million shares trading.

What is Amneal Pharmaceuticals - Class A's Beta?

AMRX has a beta of 1.06, meaning it tends to be more sensitive to market movements. AMRX has a correlation of 0.06 to the broad based SPY ETF.

How much is Amneal Pharmaceuticals - Class A worth?

AMRX has a market cap of $2.05 billion. This is considered a Mid Cap stock.

How much money does Amneal Pharmaceuticals - Class A make?

Last quarter Amneal Pharmaceuticals - Class A reported $659 million in Revenue and $.14 earnings per share. This beat revenue expectation by $40 million and exceeded earnings estimates by $.05.

What is the highest and lowest price Amneal Pharmaceuticals - Class A traded in the last 3 year period?

In the last 3 years, AMRX stock traded as high as $6.90 and as low as $1.24.

What are the top ETFs holding Amneal Pharmaceuticals - Class A?

The top ETF exchange traded funds that AMRX belongs to (by Net Assets): VTI, VB, IWM, VBR, VXF.

Is Amneal Pharmaceuticals - Class A (AMRX) a good investment?

AMRX has outperformed the market in the last year with a price return of +274.2% while the SPY ETF gained +27.8%. AMRX has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +19.6% and +13.5%, respectively, while the SPY returned +4.2% and +2.5%, respectively.

What is the support and resistance for Amneal Pharmaceuticals - Class A (AMRX) stock price?

AMRX support price is $6.27 and resistance is $6.67 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AMRX stock will trade within this expected range on the day.